We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Due to income that the Internal Revenue Service (IRS) says was improperly shifted to other countries, GlaxoSmithKline (GSK) allegedly owes the U.S. government $2.7 billion in unpaid taxes, the company confirmed last week.